Rapid responses to health questions for fact-checkers and journalists.
A 16 de julio de 2021, el bloque de países que conforman África Oriental ha administrado la tasa más alta de dosis de vacunas contra la COVID-19 de todo el continente. Las vacunas que se han administrado en África Oriental son principalmente dosis de AstraZeneca obtenidas a través de la alianza de distribución de vacunas COVAX. La estrategia de distribución de vacunas en África Oriental da prioridad a los grupos de riesgo y depende en gran medida de que los promotores y trabajadores comunitarios de salud administren las vacunas.
Several recent studies have reached similar conclusions around transmission of COVID-19 among vaccinated individuals: 1. Individuals who are fully vaccinated transmit the virus less than those who are partially vaccinated (received one dose only) and unvaccinated individuals have the highest risk of transmission. 2. Vaccines are less effective against preventing transmission of the Delta variant, when compared to other variants of COVID-19. Vaccines can reduce transmission by preventing infections and reducing the amount of infectious virus in someone’s body if they do get sick. However, the exact rate of transmission among vaccinated individuals (though it is rare) is still uncertain. A lot of cases of infection in vaccinated people do not progress to symptomatic disease, making it harder to know who is sick and collect data on how contagious they may be.
This use of tromethamine in approved COVID-19 vaccines is safe. There is no evidence that COVID-19 vaccines with tromethamine cause serious adverse health effects. There is also no evidence that tromethamine was added to “stabilize patients” from any negative health effects of the COVID-19 vaccines. Instead, pharmaceutical companies have repeatedly stated that tromethamine is used to stabilize the vaccine itself and lengthen the time doses can be kept in storage.
Intelligence can be attributed to the overall effect of a multitude of genes passed down from parents, as well as the socio-economic environment in which one grows up. Genetic research indicates that about half of the differences in intelligence can be attributed to differences in our genetics, but intelligence is also dependent on external factors. The environment, socio-economic, and health conditions can play a big role in our intelligence.
COVID-19 vaccines do not impact development, puberty, or fertility in teenagers or children. It is not possible for the mRNA COVID-19 vaccines made by Pfizer or Moderna to interfere with a child's genetics. Like other childhood vaccines, these new immunizations will not impact puberty or fertility in teenagers.
An Intrauterine Device (IUD) is a long-acting reversible birth control that is inserted and removed into the uterus by medical professionals. The American College of Obstetricians and Gynecologists (ACOG) does not recommend that individuals remove IUDs themselves. Sometimes people may try to remove the IUD themselves to avoid the cost of visiting a physician, or if an appointment with a doctor is not available. The overall recommendation on self-removal of an IUD is mixed. Many people on social media are sharing their experiences of removing their own IUD and believe that doing so provides them with autonomy over birth control and reduces barriers to the use of IUDs, while several OB/GYNs strongly advise against doing so for safety reasons. Please consult your doctor for individual advice.
Unlike some medications, height and weight are not very important when considering vaccine dosages against COVID-19. The dosage for COVID-19 vaccines are based on age, not size. Children aged 5-11 receive 10 microgram injections three weeks apart. Kids 12-17 and older get 30 microgram dosages three weeks apart. Children still produce very robust immune system responses with smaller dosages.
Scientists are still gathering data to better understand how COVID-19 vaccines last in both young people and older adults. For people over 16, current data suggests that COVID-19 vaccine protection can last at least 6 to 8 months. This is based on studies conducted by Moderna, Pfizer and BioNTech, and Johnson & Johnson as well as other pre-print and peer-reviewed research publications. Since clinical trials have found that the vaccines work similarly in adults and children aged 5-11, it is possible that vaccine-induced immunity may last for a similar amount of time in those groups.
According to the United States National Institutes of Health (U.S. NIH), gene therapy is "...[A]n experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery."
बच्चों व किशोरों को आपातकालीन उपयोग के लिए अनुमत कोई भी कोविड-19 टीका उपलब्ध होते ही लिए जाने की सलाह दी जाती है। वैश्विक रूप से फाइजर के टीके को 12 वर्ष और उससे अधिक उम्र के बच्चों के लिए सुरक्षित माना गया है। 12 साल से कम उम्र के बच्चों के लिए अभी तक कोविड-19 के टीके उपलब्ध नहीं हैं क्योंकि इस आबादी के लिए सुरक्षा परीक्षण चल रहे हैं।
नैनोपार्टिकल मास्क सूक्ष्मजीवों को बढ़ने से रोकने में प्रभावी हो सकते हैं, लेकिन प्रत्येक मास्क में सुरक्षा के विभिन्न स्तर होते हैं और यह संभव है कि सभी सुरक्षित न होंं। इस कारण से, केवल राष्ट्रीय और अंतर्राष्ट्रीय स्वास्थ्य संगठनों द्वारा प्रमाणित मास्क ही पहने जाने चाहिए, जब यादृच्छिक नियंत्रित परीक्षण दिखा सकें कि मास्क सुरक्षित और प्रभावी हैं। अन्यथा, सर्जिकल मास्क के ऊपर कपड़े का मास्क पहनना अभी भी गैर-स्वास्थ्य पेशेवरों के लिए मास्किंग के माध्यम से कोविड-19 के प्रसार को रोकने का सबसे सुरक्षित तरीका है।
16 जुलाई, 2021 तक, पूर्वी अफ्रीका ब्लॉक का निर्माण करने वाले देशों में इस महाद्वीप में कोविड-19 टीके की अधिकतम खुराकों को उपलब्ध कराया गया है। पूर्वी अफ्रीका में जो टीके लगाए गए हैं, वे मुख्य रूप से वैक्सीन-साझाकरण गठबंधन कोवैक्स के माध्यम से प्राप्त एस्ट्राजेनेका की खुराक हैं। पूर्वी अफ्रीका में वैक्सीन रोलआउट रणनीति जोखिम वाले समूहों को प्राथमिकता देती है और टीके लगाने के लिए सामुदायिक स्वास्थ्य कार्यकर्ताओं पर बहुत अधिक निर्भर करती है।
बूस्टर शॉट एक टीके की अतिरिक्त खुराक होती है जिसे लोग पहली पूर्ण खुराक मिलने के बाद लगवाते हैं ।
يتوجب على الأطفال والمراهقين تلقي أي نوع لقاح متاح لهم لحمايتهم من كوفيد-19 وذلك بمجرد توفره. على مستوى العالم، يعتبر لقاح فايزر آمنًا للأطفال من عمر 12 وأكثر. ولم يتوفر بعد لقاحات ضد كوفيد -19 لحماية الأطفال ممن هم أقل من 12 عامًا ، حين أن سلامة اللقاحات لهذه الفئة العمرية ما زالت تحت الدراسة.
Health Desk provides on-demand and on-deadline science information to users seeking to quickly communicate complex topics to audiences.
In-house scientists provide custom explainers for critical science questions from journalists, fact-checkers and others in need of accessible breakdowns on scientific information. Topics range from reproductive health, infectious disease, climate science, vaccinology or other health areas.
Meedan's Health-Desk.org makes every effort to provide health- and science-related information that is accurate and reflects the best evidence available at the time of publication. To submit an error or correction request, please email our editorial team at health@meedan.com. All error or correction requests will be reviewed by the Health Desk Editorial and Science Teams. Where there is evidence of a factual error or typo, we will update the explainer with a correction or clarification and follow up with the reader on the status of the request.
Our scientists, writers, journalists, and experts do not engage in, advocate for, or publicize their personal views on policy issues that might lead a reasonable member of the public to see our team’s work as biased. If you have concerns or comments about potential bias in our work, please contact our editorial team at health@meedan.com.
Health Desk provides on-demand and on-deadline science information to users seeking to quickly communicate complex topics to audiences.
In-house scientists provide custom explainers for critical science questions from journalists, fact-checkers and others in need of accessible breakdowns on scientific information. Topics range from reproductive health, infectious disease, climate science, vaccinology or other health areas.
Meedan's Health-Desk.org makes every effort to provide health- and science-related information that is accurate and reflects the best evidence available at the time of publication. To submit an error or correction request, please email our editorial team at health@meedan.com. All error or correction requests will be reviewed by the Health Desk Editorial and Science Teams. Where there is evidence of a factual error or typo, we will update the explainer with a correction or clarification and follow up with the reader on the status of the request.
Our scientists, writers, journalists, and experts do not engage in, advocate for, or publicize their personal views on policy issues that might lead a reasonable member of the public to see our team’s work as biased. If you have concerns or comments about potential bias in our work, please contact our editorial team at health@meedan.com.
Nat Gyenes, MPH, leads Meedan’s Digital Health Lab, an initiative dedicated to addressing health information equity challenges, with a focus on the role that technology plays in mediating access to health through access to information. She received her masters in public health from the Harvard T. H. Chan School of Public Health, with a focus on equitable access to health information and human rights. As a research affiliate at Harvard’s Berkman Klein Center for Internet & Society, she studies the ways in which health information sources and outputs can impact health outcomes. She lectures at the Harvard T.H. Chan School of Public Health on Health, Media and Human Rights. Before joining Meedan, Nat worked at the MIT Media Lab as a health misinformation researcher.
Megan Marrelli is a Peabody award-winning journalist and the News Lead of Health Desk. She focuses on news innovation in today’s complex information environment. Megan has worked on the digital breaking news desk of the Globe and Mail, Canada’s national newspaper, and on the news production team of the Netflix series Patriot Act with Hasan Minhaj. She was a Canadian Association of Journalists finalist for a team Chronicle Herald investigation into house fires in Halifax, Nova Scotia. On top of her role at Meedan Megan works with the investigative journalism incubator Type Investigations, where she is reporting a data-driven story on fatal patient safety failures in U.S. hospitals. She holds a Master of Science from the Columbia Journalism School and lives in New York.
Anshu holds a Doctor of Public Health (DrPH) from the Harvard T.H. Chan School of Public Health, and a Humanitarian Studies, Ethics, and Human Rights concentrator at the Harvard Humanitarian Initiative. She is a Harvard Voices in Leadership writing fellow and student moderator, Prajna Fellow, and the John C. and Katherine Vogelheim Hansen Fund for Africa Awardee. Anshu’s interests include: systemic issues of emergency management, crisis leadership, intersectoral approaches to climate risk resilience, inclusion and human rights, international development, access and sustainability of global health systems, and socio-economic equity. Anshu has worked at the United Nations, UNDP, UNICEF, Gates Foundation, and the Institute of Healthcare Improvement.
Dr. Christin Gilmer is a Global Health Scientist with a background in infectious diseases, international health systems, and population health and technology. In the last 15 years, Christin has worked for the WHO, University of Oxford, World Health Partners, USAID, UNFPA, the FXB Center for Health & Human Rights and more, including volunteering for Special Olympics International’s health programs and running health- and technology-based nonprofits across the country. She obtained her Doctor of Public Health Degree at the Harvard T.H. Chan School of Public Health, her MPH at Columbia, and spent time studying at M.I.T., Harvard Kennedy School, and Harvard Business School. Christin has worked in dozens of countries across five continents and loves running programs and research internationally, but she is currently based in Seattle.
Dr. Jessica Huang is currently a COVID-19 Response and Recovery Fellow with the Harvard Kennedy School’s Bloomberg City Leadership Initiative. Previously, she worked and taught with D-Lab at MIT, leading poverty reduction and humanitarian innovation projects with UNICEF, UNHCR, Oxfam, USAID, foreign government ministries and community-based organizations across dozens of countries. She also co-founded a social enterprise that has provided access to safe drinking water to thousands in India, Nepal and Bangladesh. Formerly trained as an environmental engineer, she earned a Doctorate of Public Health from Harvard and a Master’s in Learning, Design and Technology (LDT) from Stanford. Her projects have won multiple awards, including the top prize in A Grand Challenge for Development: Technology to Support Education in Crisis & Conflict Settings, and led to her being recognized for Learning 30 Under 30. She enjoys being an active volunteer, supporting several non-profits in health, education, environmental sustainability and social justice.
Jenna Sherman, MPH, is a Program Manager for Meedan’s Digital Health Lab, an initiative focused on addressing the urgent challenges around health information equity. She has her MPH from the Harvard T.H. Chan School of Public Health in Social and Behavioral Sciences, with a concentration in Maternal and Child Health. Prior to her graduate studies, Jenna served as a Senior Project Coordinator at the Berkman Klein Center for Internet and Society at Harvard Law School, where she worked on tech ethics with an emphasis on mitigating bias and discrimination in AI and health misinformation online. Previous experiences include helping to develop accessible drug pricing policies, researching access to quality information during epidemics, and studying the impact of maternal incarceration on infant health.
Nour is a Global Health Strategy consultant based in Dakar (Senegal) and specialized in health system strengthening. Most recently, she worked with Dalberg Advisors focusing on Epidemic Preparedness & Response and Vaccination Coverage and Equity across 15 countries in Sub-Saharan Africa. Her previous work experiences include researching the clinical needs in point-of-care technology in cancer care at the Dana-Farber Cancer Institute in Boston; and coordinating the implementation of a colonoscopy quality assurance initiative for a colorectal cancer screening program at McGill University in Montreal. Nour has a Master of Public Health from the Harvard T.H. Chan School of Public Health, a Master of Arts in Medical Ethics and Law from King’s College London, and a Bachelor of Science from McGill University. She is fluent in French and English.
Shalini Joshi is a Program Lead at Meedan and formerly the Executive Editor and co-founder of Khabar Lahariya - India’s only independent, digital news network available to viewers in remote rural areas and small towns. Shalini transformed Khabar Lahariya from one edition of a printed newspaper to an award-winning digital news agency available to over ten million viewers. She has a sophisticated understanding of local media and gender, and the ways in which they can inhibit women from participating in the public sphere in South Asia. Shalini was a TruthBuzz Partner & Fellow with the International Center for Journalists (ICFJ). She is a trainer in journalism, verification and fact-checking. She has designed, implemented and strengthened news reporting & editorial policies and practices in newsrooms and fact-checking organisations. Shalini set up and managed the tipline used to collect WhatsApp-based rumors for Checkpoint, a research project to study misinformation at scale during the 2019 Indian general elections.
Mohit Nair currently serves as Partnerships Director at FairVote Washington, a non-profit organisation based in Seattle, WA. Previously, he worked with the Medecins Sans Frontieres (MSF) Vienna Evaluation Unit and with MSF Operational Centre Barcelona in India. He has conducted research studies on diverse topics, including the drivers of antibiotic resistance in West Bengal and perceptions of palliative care in Bihar. Mohit has also worked as a research consultant with Save the Children in Laos to identify gaps in the primary health system and develop a district-wide action plan for children with disabilities. He holds a Master of Public Health from the Harvard University T.H. Chan School of Public Health and a Bachelor of Science from Cornell University.
Seema Yasmin is an Emmy Award-winning medical journalist, poet, physican and author. Yasmin served as an officer in the Epidemic Intelligence Service at the U.S. Centers for Disease Control and Prevention where she investigated disease outbreaks. She trained in journalism at the University of Toronto and in medicine at the University of Cambridge. Yasmin was a finalist for the Pulitzer Prize in breaking news in 2017 with a team from The Dallas Morning News and received an Emmy Award for her reporting on neglected diseases. She received two grants from the Pulitzer Center on Crisis Reporting and was selected as a John S. Knight Fellow in Journalism at Stanford University iin 2017 where she investigated the spread of health misinformation and disinformation during epidemics.
Dr. Saskia Popescu is an infectious disease epidemiologist and infection preventionist with a focus on hospital biopreparedness and the role of infection prevention in health security efforts. She is an expert in healthcare biopreparedness and is nationally recognized for her work in infection prevention and enhancing hospital response to infectious diseases events. Currently, Dr. Popescu is an Adjunct Professor with the University of Arizona, and an Affiliate Faculty with George Mason University, while serving on the Coronavirus Task Force within the Federation of American Scientists, and on a data collection subcommittee for SARS-CoV-2 response with the National Academies of Science, Engineering, and Medicine. She holds a PhD in Biodefense from George Mason University, a Masters in Public Health with a focus on infectious diseases, and a Masters of Arts in International Security Studies, from the University of Arizona. Dr. Popescu is an Alumni Fellow of the Emerging Leaders in Biosecurity Initiative (ELBI) at the Johns Hopkins Bloomberg School of Public Health, Center for Health Security. She is also an external expert for the European Centre for Disease Control (ECDC), and a recipient of the Presidential Scholarship at George Mason University. In 2010, she was a recipient of the Frontier Interdisciplinary eXperience (FIX) HS-STEM Career Development Grant in Food Defense through the National Center for Food Protection and Defense. During her work as an infection preventionist, she managed Ebola response, a 300+ measles exposure resulting in an MMWR article, and bioterrorism preparedness in the hospital system. More recently, she created and disseminated a gap analysis for a 6-hospital system to establish vulnerabilities for high-consequence diseases, helping to guide the creation of a high-consequence disease initiative to enhance readiness at the healthcare level.
Ben Kertman is a behavior change scientist and public health specialist who became a user research consultant to help organizations design experiences that change behaviors and improve human well-being. Impatient with the tendency of behavior change companies to use a single discipline approach (e.g. behavioral economics) and guard their methods behind paywalls, Ben spent the last 7 years developing an open-source, multi-discipline, behavior change framework for researchers and designers to apply to UX. Ben is an in-house SME at Fidelity Investments and consults for non-profits on the side. Ben holds a masters in Social and Behavior Science and Public Health from Harvard.
Emily LaRose is a Registered Dietitian and Nutrition and Global Health Consultant who, in addition to her work with Meedan, currently works as a Technical Advisor for Nutrition for Operation Smile. She has been a dietitian for more than 18 years and, over the past 10 years, she has worked for the World Bank, Global Alliance for Improved Nutrition (GAIN), Médecins Sans Frontières (MSF), PATH, Johnson & Wales University, and Children’s Hospital Los Angeles. In her work, she has conducted analytical research and written specialty reports on infant and young child malnutrition, health misinformation, global human milk banking practices, and innovative food system programs; developed tools and protocols for clinical nutrition care delivery in humanitarian hospitals; taught university-level nutrition courses; and provided nutritional care for critically ill hospitalized patients. Emily earned her Doctor of Public Health (DrPH) degree with a Nutrition and Global Health Concentration at the Harvard T.H. Chan School of Public Health, her Master of Science in Dietetics at Kansas State University, and her Bachelor of Science in Culinary Arts Nutrition at Johnson & Wales University.
Bhargav Krishna is a Fellow at the Centre for Policy Research in Delhi, and adjunct faculty at the Public Health Foundation of India and Azim Premji University. He previously managed the Centre for Environmental Health at the Public Health Foundation of India, leading research and teaching on environmental health at the Foundation. He has been a member of Government of India expert committees on air pollution and biomedical waste, and has led work with Union and State governments on air pollution, climate change, and health systems. His work has been funded by the World Health Organization, Rockefeller Foundation, Packard Foundation, Environmental Defense Fund, and others. He holds bachelors and masters degrees in Biotechnology and Environmental Science respectively, and graduated recently from the Doctor of Public Health program at the Harvard T. H. Chan School of Public Health. Bhargav also co-founded Care for Air, a non-profit working on raising awareness related to air pollution with school children in Delhi.
Dr. Christine Mutaganzwa is a medical doctor pursuing a Ph.D. program at the Université de Montréal in Biomedical Sciences. She holds a Master of Medical Sciences in Global Health Delivery (MMSc-GHD) from Harvard Medical School, Boston, MA, and a Master of Sciences (MSc) in Epidemiology and Biostatistics from the University of Witwatersrand, Johannesburg, South Africa. She graduated from the University of Rwanda with a degree in General Medicine and Surgery. Christine has worked with referral hospitals in Kigali, the capital city of Rwanda, during her medical training and after graduation. In addition, she has extensive experience working with rural communities in the Eastern province of Rwanda, where she organized clinical and research activities in active collaboration with colleagues within and outside Rwanda. Her research portfolio cuts across maternal and child health to infectious and chronic diseases. Christine is an advocate for children's healthcare services, especially for underserved populations. She is part of a community of scientists translating scientific findings into understandable and accessible information for the general population. Christine is an avid reader and a lover of classical/contemporary music.
Ahmad is an experienced physician, who earned his medical degree from Cairo University, Faculty of Medicine, in Egypt. He practiced medicine between 2012 and 2017 as a general practitioner where he was involved in primary care, health quarantine services, and radiology. He then taught medicine in Cairo for two years prior to starting his MPH program, at the Harvard T.H. Chan School of Public Health, where he supplemented his experience with knowledge on epidemiology, health systems and global health issues. Additionally, Ahmad has an interest in nutrition, which started as a personal curiosity to how he can improve his own health, then quickly saw the potential for public health nutrition in the prevention and management of multiple, lifelong diseases. His enrollment at Harvard started his transition towards learning about food, and public health nutrition. Ahmad now combines the knowledge and experience of his medical career, with the learnings of his degree to navigate public health topics in his writing and his career. He is a life-long learner and continues to gather knowledge and experience, and works towards maximizing his impact through combatting misinformation through his work with Meedan.
Dr. Uzma Alam is a global health professional working at the intersection of infectious diseases and healthcare delivery in the international development and humanitarian contexts. She focuses on the use of evidence and innovation to inform strategies and policies. Her work has appeared globally across print and media outlets.She has international experience with roles of increasing responsibility across the science value chain having served with academic, non-profit, corporate, and governmental agencies, including advisory commissions and corporate counsel. Uzma is the former secretary of the Association of Women in Science and editor of the Yale Journal of Health Policy, Law, and Ethics. Currently she serves on the Board of the Geneva Foundation. She also leads the Biomedical and Health Sciences Portfolio of the Developing Excellence, Leadership and Training in Science in Africa program (DELTAS-Africa). A US$100 million programme supporting development of world-class scientific leaders on the continent. Plus heading the African Science, Technology, and Innovation (STI) Priorities Programme. A programme that engages Africa’s science and political leaders to identify the top STI priorities for the continent that if addressed, offer the highest return on investment for Africa’s sustainable development.